Erykine Indications/Uses

Anaemia Associated with Chronic Renal Failure. Anaemia Associated with Chronic Renal Failure in Hemodialysis in Adults, on Peritoneal Dialysis and Non-dialysis Adults: ERYKINE is indicated for the treatment of anemia associated with CRF, including patients on dialysis (ESRD) and patients not on dialysis. ERYKINE is indicated to elevate or maintain the red blood cell level (as manifested by the hematocrit or hemoglobin determinations) and to decrease the need for transfusions in these patients.
Treatment of Anemia in Cancer Patients on Chemotherapy: ERYKINE is indicated for the treatment of anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy.
Treatment of Anemia in Zidovudine-treated HIV-infected Patients: ERYKINE is indicated for the treatment of anemia related to therapy with zidovudine in HIV-infected patients. ERYKINE is indicated to elevate or maintain the red blood cell level (as manifested by the hematocrit or hemoglobin determination) and to decrease the need for transfusions in these patients.
Reduction of Allogeneic Blood Transfusion in Surgery Patients: ERYKINE is indicated for the treatment of anemic patients (hemoglobin > 10 to ≤ 12 g/dL) scheduled to undergo elective, noncardiac, nonvascular surgery to reduce the need for allogeneic blood transfusions. ERYKINE is indicated for patients at high risk for preoperative transfusions with significant, anticipated blood loss.
ERYKINE is not indicated for anemic patient who are willing to donate autologous blood. The safety of the preoperative use of ERYKINE has been studied only in patients who are receiving anticoagulant prophylaxis.